eLaws
|
eCases
|
United States Code
|
Federal Courts
|
Sign In
Sign Up
eLaws
eCases »
United States Code
Federal Courts »
Home
»
Rulemaking
» Draft Guidances for Industry: Self-Identification of Generic Drug Facilities, Sites, and Organizations
Draft Guidances for Industry: Self-Identification of Generic Drug Facilities, Sites, and Organizations
Document ID:
FDA-2012-D-0881-0001
Document Type:
Notice
Agency:
Food And Drug Administration
Topics:
No Topics associated with this document
Federal Register Number:
2012-20946
View Document:
Details Information
Abstract:
The docket number is incorrect, this should had been FDA-2012-D-0881 (mb) 8/27/2012
Document Subtype:
Notice of Availability
Received Date:
August 27 2012, at 12:00 AM Eastern Daylight Time
Start-End Page:
51811 - 51814
Page Count:
4
Comment Start Date:
August 27 2012, at 12:00 AM Eastern Standard Time
Comment Due Date:
October 26 2012, at 11:59 PM Eastern Standard Time
Comments
Total:
1
Bulk Pharmaceutical Task Force (BPTF) - Comment
Posted:
11/01/2012
ID:
FDA-2012-D-0881-0004
Comment Period Closed
Oct 26,2012 11:59 PM ET
Related Documents
Total:
0
No documents available.
Draft Guidances for Industry: Self-Identification of Generic Drug Facilities, Sites, and Organizations
Details Information
Comments
Posted: 11/01/2012 ID: FDA-2012-D-0881-0004
Oct 26,2012 11:59 PM ET
Related Documents